Back
Sabre Corp. 10K Form
Sell
13
SABR
Sabre Corp.
Last Price:
$0.90
Seasonality Move:
-13.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | SABR/Sabre Corp. Quarterly |
| 2023-11-02 | 10Q | SABR/Sabre Corp. Quarterly |
| 2023-08-03 | 10Q | SABR/Sabre Corp. Quarterly |
| 2023-05-04 | 10Q | SABR/Sabre Corp. Quarterly |
| 2022-11-02 | 10Q | SABR/Sabre Corp. Quarterly |
| 2022-08-02 | 10Q | SABR/Sabre Corp. Quarterly |
Receive SABR News And Ratings
See the #1 stock for the next 7 days that we like better than SABR
SABR Financial Statistics
Sales & Book Value
| Annual Sales: | $2.8B |
|---|---|
| Cash Flow: | $113.3M |
| Price / Cash Flow: | 40.62 |
| Annual Sales: | $-2.66 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 1.13810 |
|---|---|
| Net Income (TTM): | $-216.6M |
| Gross Margin: | $1.6B |
| Return on Equity: | 0% |
| Return on Assets: | -4.79% |
Sabre Corp. Earnings Forecast
Key Sabre Corp. Financial Ratios
-
The Gross Profit Margin over the past 16 years for SABR is 56.44%.
-
The Selling, General & Administrative Expenses for SABR have been equal to 20.12% of Gross Profit Margin.
-
The Research & Development expenses have been 25.66% of Revenue.
-
The Net Earning history of SABR is -9.22% of Total Revenues.
-
Per Share Earnings over the last 16 years have been positive in 10 years.
Sabre Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Hotels, Restaurants & Leisure |
| Sector: | Consumer Discretionary |
| Current Symbol: | SABR |
| CUSIP: | 78573M |
| Website: | sabre.com |
Debt
| Debt-to-Equity Ratio: | -4.2 |
|---|---|
| Current Ratio: | 1.07 |
| Quick Ratio: | 1.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 0.73 |
|---|---|
| Forward P/E Ratio: | 3.89 |
SABR Technical Analysis vs Fundamental Analysis
Sell
13
Sabre Corp. (SABR)
is a Sell
Is Sabre Corp. a Buy or a Sell?
-
Sabre Corp. stock is rated a SellThe current Sabre Corp. [SABR] share price is $0.98. The Score for SABR is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.